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Leech embryogenesis is a model for investigating cellular and molecular processes of development. Due to the unusually large size
of embryonic stem cells (teloblasts: 50–300μm) in the glossiphoniid leech, Theromyzon tessulatum, and the presence of identiﬁable
stem cell precursors (proteloblasts), we previously isolated a group of genes upregulated upon stem cell birth. In the current
study, we show that one of these genes, designated Theromyzon proliferation (Tpr), is required for normal stem cell genesis;
speciﬁcally, transient Tpr knockdown experiments conducted with antisense oligonucleotides and monitored by semiquantitative
RT-PCR, caused abnormal proteloblast proliferation leading to embryonic death, but did not overtly aﬀect neuroectodermal or
mesodermal stem cell development once these cells were born. Tpr encodes a large glutamine-rich (∼34%) domain that shares
compositionalsimilaritywithstrongtranscriptionalenhancersmanyofwhichhavebeenlinkedwithtrinucleotiderepeatdisorders
(e.g., Huntington’s).
1.Introduction
Stem cells (SCs) are unique in that they self-renew and
generatediﬀerentiatedcelltypes;knowledgeofthegenesthat
govern these processes is clearly important in determining
their genetic potential. Various transcriptional proﬁling
eﬀorts have identiﬁed candidate genes involved in SC self-
renewal and potency [1–3], but little overlap occurs between
gene datasets, which has called these analyses into question
[4]. Nonetheless, a few genes are generally linked with stem
cell genesis or maintenance (e.g., Oct4 [5]; Nanog [6];
Sox2 [7]), and certain combinations of transcription factors
appear suﬃcient to promote stem cell fate when ectopically
expressed in some nonstem cell types [8, 9].
Current stem cell research has focused on mammalian
SCs, but we have explored this topic in an invertebrate model
system, the leech Theromyzon tessulatum, which transiently
displays embryonic SCs that have properties similar to
mammalian adult SCs [10]. Leech oﬀers a new perspective
to this arena because stem cell precursors (proteloblasts) and
stem cells (teloblasts) are experimentally accessible during
development and, in contrast to mammalian embryonic
cells, homogeneous populations of both leech cell types
can be prepared by relatively simple dissections (Figure 1).
Leech proteloblasts and teloblasts are particularly large (50–
400μm), which permits cell type-speciﬁc microinjections of
molecular reagents (e.g., lineage tracers, nucleic acids), and
they appear at predictable spatiotemporal positions during
embryogenesis (Figure 1). Speciﬁcally, the mesodermal pro-
teloblast(DM)andectodermalproteloblasts(NOPQleftand
right) are derived from the D quadrant macromere within
∼10 hours after fertilization and persist for an ∼1h o u r
time window; thereafter, each proteloblast gives rise to its
respective teloblast(s) lineage at the rate of ∼1c l e a v a g ep e r
hour (i.e., DM cleavage generates left and right M teloblasts,
and NOPQ gives rise to N, OP, Q, O, and P teloblasts in
successive cleavages).
Taking advantage of these developmental features,
we previously used diﬀerential display-PCR (DD-PCR)
methodology to identify a set of unbiased (i.e., noncandidate
gene approach), diﬀerentially expressed genes, several of
which are upregulated upon the birth of teloblasts [10].
Following up on our previous work, we report here that one
teloblast-speciﬁc gene, designated Theromyzon proliferation
(Tpr), encodes a glutamine-rich protein that plays a critical
role in teloblast formation. Speciﬁcally, Tpr is up-regulated
during the conversion of proteloblasts to teloblasts, and
Tpr knockdown experiments disrupt normal cell cleavage2 Stem Cells International
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Figure 1: Schematic of early development in glossiphoniid leeches. After several asymmetric cleavages, proteloblasts DM (stage 4) and
NOPQ (stage 5) are stereotypically positioned on the embryo’s surface. A series of unequal divisions leads to ﬁve bilaterally paired stem cells
(10 total), or teloblasts (gray cells: M, N, O, P, Q), that give rise to chains of segmental founder cells called bandlets (stages 7, 8). By epiboly,
bandlets move across the surface of the embryo (arrows, stage 8) and coalesce to form the segmental mesodermal and ectodermal tissue.
Modiﬁed from Hohenstein and Shain [10].
patterns resulting in the abnormal proliferation of targeted
proteloblast, but not teloblast, cells.
2.MaterialsandMethods
2.1. Leeches and Embryo Collection. Adult Theromyzon tes-
sulatum specimens, formerly confused with T. rude or T.
trizonare [11], were collected in the ponds of Golden Gate
Park (San Francisco, CA). Leeches were maintained at 12
◦C
in 0.03% Instant Ocean Salt (Aquarium Systems). Embryos
were staged by visual inspection under a stereomicroscope,
and appropriate stages were harvested as described [10].
2.2. Diﬀerential Display-PCR. Microdissection and collec-
tion of individual cells from leech embryos and their
transcriptional proﬁling by diﬀerential display-PCR (DD-
PCR) were conducted as described in [10]. DD-PCR bands
were ampliﬁed according to the manufacturer’s protocol
(Clontech); bands were gel puriﬁed with a Minielute Gel
Extraction kit (Qiagen) and cloned into pGEM-T Easy
(Promega). DNA was sequenced commercially (Northwoods
DNA, Inc., Becida, MN) with standard T7 or Sp6 primers.
2.3. cDNA Library Screening and RACE (Rapid Ampliﬁcation
of cDNA Ends). λ Triplex2 cDNA libraries were constructed
from ∼100 stage 1 T. tessulatum embryos (maternal library)
and an assortment of stages 1–9 embryos (embryonic
library) using SMART methodology (Clontech). Library
screening was conducted under high stringency by standard
procedures [12], with [ 32P]-dCTP PCR-labeled probes.
RACE-PCR was conducted using Tpr-speciﬁc oligonu-
cleotides (TprA-D; see below) derived from the original
diﬀerentially expressed Tpr fragment [10].
2.4. Oligonucleotide Microinjections. Oligonucleotides were
synthesizedcommercially(Sigma-Genosys).Antisenseoligo-
nucleotides were TprA—TTGATATTACTGCCAGCATG,
TprB—TGTAGTTGTCGTTGATGTTG; sense oligonucleot-
ides wereTprC—TGCAACACATTCGACATCAC, TprD—
AACACACGACAACAACAACG. Oligonucleotides were
resuspended in H2O at 1mM and coinjected with ﬂuores-
cent lineage tracer (either ﬂuorescein-dextran amine (FDA,
Molecular Probes) or tetramethylrhodamine-dextran amine
(RDA, Molecular Probes)) as described [13].
2.5. Imaging. Embryos were viewed on a Zeiss Axioplan
equipped with epiﬂuorescence. Images were captured with
a Nikon Coolpix 5000 camera and processed in Photoshop
(Adobe).
2.6. Semiquantitative Reverse Transcription—Polymerase
Chain Reaction (RT-PCR). Total RNA was extracted
using the Total RNA Isolation System (Promega) and
reverse transcribed with Powerscript (Clonetech). First-
strand cDNA was ampliﬁed using commercially synthesized
(Sigma-Genosys), gene-speciﬁc primers and 18S ribosomalStem Cells International 3
Tpr
S
t
a
g
e
4
D
M
M
N
O
P
Q
N
S
t
a
g
e
7
(a)
Tpr
18S
Stage
13 467 8
(b)
Figure 2: Diﬀerential expression of Tpr during leech embryo-
genesis. (a) Diﬀerential display analysis shows faint Tpr bands
(boxed with pinholes) in teloblast lanes M and N, and in stage
7 embryos which contain teloblasts M, N, O, P and Q. Bands
above and below appear in all lanes and are likely “housekeeping”
genes. (b) Semi-quantitative RT-PCR analysis shows declining Tpr
transcripts during stage 1 (presumably maternal) through stage 4;
accumulation of new zygotic transcripts was evident thereafter and
peaked at stage 7. Lanes were normalized with 18S rRNA primers.
RNA primers.RT-PCR primer sets are listed below with
approximate fragment size:Tpr1—TTGTCAAAACAACGT-
GACAAC ,T p r 2 — GGTTTTTGTTGTTGAATG-
CTG(270bp);18S ribosomalRNA—GCTTGTCTCAAA-
GATTAAGCC, AACTACGAGCTTTTTAACTGC (610bp).
RT-PCRwas conducted with Titanium Taq DNA polymerase
(Clontech) using the following parameters: 94
◦C( 1 5
seconds); 57
◦C( 1m i n u t e ) ;7 2
◦C (1 minute) for 32 cycles.
Each presented lane is representative of at least three
independent experiments.
3. Results
Among several genes upregulated upon the birth of leech
teloblasts, Tpr displayed an unambiguous, albeit weak,
teloblast-speciﬁc expression proﬁle in diﬀerential display
(DD) analysis (i.e., bands in M and N teloblast lanes and
also stage 7 embryos; see Figure 2(a)). Relatively weak
DD bands were consistent with negative Northern blots
using a Tpr probe, suggesting that Tpr is likely a rare
transcript. To verify the DD pattern of Tpr and further
analyze its temporal expression during leech embryogenesis,
semiquantitative reverse transcriptase-PCR (RT-PCR) was
conducted using appropriately staged Theromyzon tessula-
tumembryos.Embryosatstages1–4(containingproteloblast
cells), stage 6 (containing all 10 teloblasts), and stages 7 and
8 (containing teloblasts and bandlets—see Figure 1)w e r e
collected and processed for RT-PCR. To normalize reactions,
18S ribosomal RNA was coampliﬁed in all reactions. These
analyses demonstrated that Tpr was upregulated in embryos
containing teloblasts, in comparison with their immediate
precursors, DM, and NOPQ (Figure 2(b)). Surprisingly, Tpr
mRNA was also detected in the fertilized egg (stage 1),
indicatingitspresenceasamaternalmRNA.Transcriptlevels
declined during early cleavages until reaching near back-
ground levels in stage 4 embryos, which contain proteloblast
cells, DM and NOPQ. Comparable declines of maternal
t r a n s c r i p t sh a v eb e e no b s e r v e di nl e e c h( e . g . ,nanos [14])
and other organisms (e.g., mouse [15]). Coincident with the
birth of teloblasts, Tpr levels increased until reaching peak
levels at stage 7 (containing teloblasts and bandlets) before
declining by stage 8.
B e c a u s eD Da n a l y s i sg e n e r a t e so n l yg e n ef r a g m e n t s ,
T. tessulatum cDNA libraries were screened in eﬀorts to
obtain additional Tpr cDNA sequences. Overlapping cDNA
fragmentsobtainedfrommultiplelibraryscreensandRACE-
PCR products generated a combined linear sequence of
775bp that includes a glutamine-rich (∼34%) open reading
frame of 249 amino acids (Figure 3). Curiously, the 3
  end of
Tpr appears unrepresented in our oligo dT-primed maternal
and embryonic cDNA libraries, suggesting an internal A-rich
segment(notetheabundanceofCAAandCAGrepeatsinthe
available sequence), and we were unable to obtain additional
3
  sequence by RACE-PCR using staged 1st strand cDNA
as template. Likewise, 3
  sequences beyond that shown in
Figure 3 were not detected in our available T. tessulatum
genomic library.
To examine the function of Tpr in developing embryos,
an assortment of antisense (AS) oligonucleotides was gen-
erated to transiently knockdown Tpr mRNA levels dur-
ing embryogenesis. To control for speciﬁcity and toxicity,
independent sense oligonucleotides were microinjected into
developing embryos at various stages, none of which caused
overt embryonic defects (Figure 4(a)). However, microin-
jection of three independent Tpr AS oligonucleotides into
the D macromere of stage 3 embryos (see Figure 1) caused
abnormal cell divisions of DM and NOPQ cells, leading to
disorganized cell clusters (representative phenotypes shown
in Figures 4(b) and 4(c)). Note that AS oligonucleotides
targeting other teloblast-speciﬁc genes identiﬁed in our
original DD-PCR analysis displayed fundamentally diﬀerent
phenotypes (e.g., bandlet truncation), none of which were
related to the abnormal proliferation resulting from Tpr AS
oligonucleotides [16]. In total, we observed this clustered
cell phenotype in >300 experimental embryos from >5
independent clutches, with ∼95% of embryos aﬀected;
the remaining embryos were typically overinjected and
did not divide further following the initial microinjection.
The eﬃcacy of independent AS oligonucleotides varied
(consistent with other reports [17]), with TprB (both4 Stem Cells International
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750
755
T AA ATTGCGTTCTTTTCATACTAATAATGGTGATGATGATAGTAATGG
MV MMI V MV
VVM M M M M M VM M LRVGVS
VI I TNSRQQPLQQQPL
Q QQPL QQQQQL L QQQRV
Q KLPQ KLPPPQ FKRQ LY
ADTLKHDNKTCQNNVT
T TI TATTNVQHAGSNI N
NTS TQQQL QHQQQL QQQ
QTL QHVRHHQQCNTQQ
A PQQEHTTTTTI I KQQS
I CQQI QQQQQHS TTKTT
TAPTTNNQI NETQRSR
K KNRKRKAKLKQQELQQ
QQQQQRRQQKQI QQQQQ
QVQQQQPQPQQQPQQQ
Q PPPQQRQ
G C
GGTGGTGATGATGATGATGATGATGGTGATGATGTTAAGAGTGGGGGTAA
GTGTCATCATCACCAACTCCAGACAACAACCATTACAACAACAACCATTA
CAACAACAACCATTACAACAACAACAACAATTATTACAACAGCAGCGGGT
ACAAAAATTACCACAAAAATTACCACCACCACAGTTTAAACGACAGCTGT
ATGCTGACACGCTTAAGCATGACAATAAAACTTGTCAAAACAACGTGACA
ACAACAATAACAGCAACAACAAACGTACAACATGCTGGCAGTAATATCAA
CAACACATCAACACAACAACAGCTACAACATCAACAACAACTACAACAAC
AACAAACATTGCAACACGTTCGACATCACCAACAATGCAACACACAACAG
GCACCACAACAAGAACACACGACAACAACAACGATAATAAAACAACAATC
TATTTGCCAACAAATACAACAACAACAACAGCATTCAACAACAAAAACCA
CTACAGCGCCTACCACCAACAACCAAATAAATGAAACACAGAGATCGAGG
AAAAAAAATAGAAAAAGAAAGGCTAAATTAAAACAACAAGAGCTGCAGCA
ACAACAACAACAGCAAAGACGACAACAAAAACAAATACAGCAACAACAAC
AACAAGTACAACAACAACAACCTCAACCTCAACAACAGCCACAACAACAA
CAACCACCACCACAACAACGACAAT
Figure 3: Tpr nucleotide and predicted amino acid sequences (GenBank accession no. EU527977). The available ORF encodes a protein
domain that contains ∼34% glutamine. Shaded sequences identify the positions of oligonucleotides TprA (330–350), TprB (378–397), TprC
(410–429), TprD (464–483), Tpr1 (292–302), and Tpr2 (529–549) that were employed for microinjections, RACE-PCR and RT-PCR (see
Section 2).
(a) (b) (c)
Figure 4: Proliferated cell clusters generated after microinjecting Tpr antisense oligonucleotides into developing Theromyzon tessulatum
embryos. (a) Normal, mid-stage 8 embryo ﬁxed ∼48 hours after coinjecting sense oligonucleotide TprC and RDA (red) into the D
macromere. (b) Representative embryo ﬁxed ∼48 hours after co-injecting antisense oligonucleotide TprB and FDA (green) into the D
macromere. (c) Sampling of embryos from the same experimental group as in (b). Scale bar = 100μm (a), (b); 250μm( c ) .Stem Cells International 5
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Figure 5: Transient knockdown of Tpr mRNA as monitored
by semi-quantitative PCR. Antisense oligonucleotide TprB was
microinjected into the D macromere of ∼50 embryos, and ∼12
embryos were harvested 6 (stage 6), 12 (stage 7), 24 (early stage
8) and 45 (mid-stage 8) hours later, respectively. Tpr mRNA levels
were apparent by 24 hours post-injection in proliferated embryos.
Control (no injection) and sense (TprC) microinjections were
conductedinthesameexperimentalclutchandharvestedat6(stage
6) and 12 (stage 7) hours post-injection, respectively. Lanes were
normalized with 18S rRNA primers.
phosphodiester and phosphorothioate linked) displaying a
stronger phenotype than others tested; consequently, AS
oligonucleotide TprB was employed for subsequent analyses.
Note that disorganized cells could not be counted accurately
since they formed three-dimensional arrays; however, our
estimates suggest that the total number of cells in TprB-
injected embryos approximated the normal number of cells
in comparably staged embryos, if micromeres were factored
into the counts (compare also control versus experimental
embryos in Figure 6). About 48 hours postinjection, cell
proliferation ceased and embryos died shortly thereafter.
Typically, several hundred abnormal cells (roughly equal
in size; see Figures 4(b) and 4(c)) were derived from one
antisense-injected D macromere.
Semi-quantitative RT-PCR analyses demonstrated that
Tpr mRNA levels were knocked down in the experiments
described above (Figure 5). Speciﬁcally, Tpr transcripts were
not detected in AS-injected embryos undergoing abnormal
proliferation at 6 hours (stage 6) or 12 hours (stage 7)
post-injection, yet were readily detected in corresponding
uninjected and sense-injected control embryos, respectively
(Figure 5). By ∼24 hours post-injection (early stage 8 in
normal embryos) Tpr transcripts appeared in AS-injected
embryos, and increased further at ∼45 hours (mid-stage 8
in normal embryos), just prior to embryonic lethality.
To determine the time window in which Tpr expression
was critical for normal development, diﬀerent cell types
were microinjected with AS and sense oligonucleotides
and monitored for abnormal proliferation (Figures 6 and
7). Embryos injected with AS oligonucleotides at the 1-
2 cell stage developed normally until stage 4, at which
point the mesodermal proteloblast (DM), which normally
buds oﬀ two micromeres before dividing equally into ML
and MR teloblasts (Figure 6(a)), divided oﬀ-center (and
unpredictably) in comparison with its normal cleavage
pattern (Figures 6(b)–6(d)). Thereafter, cell cleavages in AS-
injected cells were irregular and displayed no detectable
patterns, but typically generated abnormal cell clusters with
roughly equal-sized cells (Figures 6(e)–6(l); cf. Figure 4).
Similarly, knockdown of Tpr mRNA in proteloblasts DM
and NOPQ caused abnormal cleavages in mesodermal (M)
and neuroectodermal (N, O, P, and Q) lineages, respectively
(e.g., Figure 7(a)), and also abnormal cell divisions, but to
a lesser extent than observed in earlier-staged AS injections.
In general, the extent of proliferation in each embryo was
directly related to the age of the injected cell; thus, early
embryonic injections (i.e., stages 1, 2, and 3) resulted in
larger cell clusters, while later injections (i.e., precursors DM
and DNOPQ) were less severe (Figure 7(a)).
Finally, Tpr antisense injections into M, N, and OP
teloblasts did not induce abnormal proliferation, but rather
had little or no eﬀect on subsequent development (e.g.,
bandlet formation) in comparison with contralateral, sense-
injected or noninjected teloblast lineages (Figures 7(b) and
7(c)). Note that these injections were conducted just a few
hours later than AS injections into DM (which caused dra-
matic anomalies), and levels of Tpr mRNA were likely com-
parable at the diﬀerent experimental stages (see Figure 2(b)).
Thus, a short developmental time window existed (i.e.,
a few hours preceding teloblast birth) within which Tpr
mRNA knockdown experiments prevented normal teloblast
genesis, suggesting that inhibiting the onset of presumptive
zygotic Tpr transcription (cf. Figure 2(b))w a sm o r ec r u c i a l
for normal teloblast development than knocking down Tpr
transcripts once teloblasts were born.
4. Discussion
By comparing gene expression proﬁles in proteloblast and
teloblast cells, we isolated a relatively small set of teloblast-
speciﬁc genes [10], one of which encodes the glutamine-
rich factor designated Tpr. The deﬁned developmental time
window within which Tpr knockdown experiments were
eﬀective (i.e., a few hours prior to the birth of teloblasts)
suggests that Tpr AS oligonucleotides prevented the normal
onset of presumptive Tpr transcripts, implying that Tpr acts
primarily at the proteloblast → teloblast transition point,
and not in the maintenance of teloblasts once diﬀerentiated.
Note, however, that Tpr must act prior to proteloblast cleav-
age (i.e., in the proteloblast), since Tpr knockdowns clearly
aﬀected the proteloblast cleavage pattern (see Figure 6).
Considering the spatiotemporal expression of Tpr presented
here (i.e., DD-PCR, RT-PCR), we propose that Tpr is a rare
transcript expressed shortly before proteloblast cleavage and
is required for normal teloblast birth.
This time window corresponds roughly with the onset
of full-blown zygotic transcription in the related leech,
Helobdella robusta, though zygotic transcription has been
detected at the 2-cell stage [18]. Full transition to zygotic
control in leech is similar to models like sea urchin, where
zygotic transcription begins during early cleavages but full
zygotic control is not present until later in development
[19]. When transcription in H. robusta was inhibited
by α-amanitin, aberrant cell cleavages resulted just prior
to teloblast formation leading to embryonic death [19],
comparable to our 6–12 hours postinjection phenotypes6 Stem Cells International
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Figure 6: Time course of cell divisions leading to proliferated cell clusters following Tpr antisense oligonucleotide microinjections into
the D macromere. (a) Normal embryo ∼6 hours after microinjection with sense oligonucleotide TprC (co-injected with RDA; red). (b)–
(d) Representative atypical cleavages ∼6 hours after microinjection with antisense oligonucleotide TprB (co-injected with FDA; green). (e)
Normal embryo ∼12 hours post-injection. (f)–(h) Antisense injected embryos ∼12 hours post-injection. (i) Normal embryo ∼24 hours
post-injection. (j)–(k) Antisense injected embryos ∼24 hours post-injection. Scale bar = 200μm.
(a) (b) (c)
Figure 7: Tpr antisense oligonucleotides aﬀected proteloblast, but not teloblast, cell development. (a) Proteloblast NOPQ (right) was
microinjected with Tpr sense oligonucleotide TprC (co-injected with RDA; red) and displayed a normal bandlet pattern, while NOPQ
(left) microinjected with Tpr antisense oligonucleotide TprB (co-injected with FDA; green) proliferated abnormally; representative embryo
harvested at ∼36 hours post-injection. (b) M (right) teloblast microinjected with TprC (sense; red) appeared normal ∼50 hours later; M
(left) microinjected with TprB (antisense; green) also appeared normal (the disparity in the extent of each germinal band resulted from the
∼2 hours delay between sense and antisense microinjections). (f) N (right) teloblast microinjected with TprC (sense; red) appeared normal
∼72 hours later; N (left) microinjected with TprB (antisense; green) appeared relatively normal. Scale bar = 200μm.Stem Cells International 7
(see Figure 6)b u td i ﬀering in the extent of abnormal cell
divisions and time frame of lethality. Nonetheless, parallels
between the two studies are evident, and diﬀerences may
be related to the number of genes targeted in each study
and/or species-speciﬁc developmental variation; indeed,
morphologically indistinguishable species of Helobdella not
only diverge signiﬁcantly in their genome sequence, but also
display notable dissimilarities in developmental processes
[20].
4.1. Cell Proliferation. The extent to which embryonic cells
proliferated following Tpr AS injections into proteloblast
cells has not been previously observed in leech, but the
propensity of embryonic cells to proliferate abnormally has
been documented by the misexpression of several genes,
particularly in the fruit ﬂy, Drosophila melanogaster. For
example, a lethal giant larvae knockout causes abnormal
proliferation of neuroblasts in epithelia [21], mutations in
Rpb9 that prevent its expression in stage 3 egg chambers
cause cystocytes to overproliferate leading to an ovarian
tumor phenotype [22], and loss of notch signaling in the
central nervous system causes extensive cell proliferation
[23]. Although we are currently unable to establish the
mechanism by which Tpr downregulation causes abnormal
cell proliferation, our data link zygotic Tpr expression with
the normal birth of leech teloblasts; when zygotic Tpr
expression is inhibited, proteloblast cells displayed irregular
cleavages that led to abnormal cell masses and embryonic
death. In principle, the Tpr gene product may be associated
with the orientation of the proteloblast cleavage plane; loss
of this control may disrupt normal partitioning, cell-cell
interactions and/or signaling leading to the constitutive
division of daughter cells (cf. lethal giant nerve, Rpb9, and
notch knockouts described previously).
4.2. Glutamine-Rich Proteins. Glutamine-rich domains have
been linked with protein-protein interactions (e.g., polar
zippers) that inﬂuence transcription. For instance, the strong
enhancer protein Sp1 interacts with components of TFIID
through a glutamine-rich domain [24], and notch signaling
is mediated by LAG3, a glutamine-rich transcription factor
that lacks a DNA binding motif [25]. The propensity of
CAG trinucleotide repeats to expand during gametogenesis
(leadingtostretchesofglutaminerepeats)isthefundamental
cause of Huntington’s and related diseases [26, 27]a n d
contributes to the lack of sequence similarity observed
between glutamine-rich homologues of related taxa [28].
We were nonetheless surprised to ﬁnd only compo-
sitional matches (i.e., glutamine-rich domains) to Tpr in
GenBank; on the other hand, transcription factors with
homopolymeric runs of speciﬁc amino acids (i.e., Gln,
Ser, Ala, Pro, Gly) that are components of well-conserved
Hox gene regulatory pathways (e.g., lag-3 and sop-3 in
C. elegans; mastermind in D. melanogaster)d on o th a v e
clear homologues in other organisms [28]. Perhaps Tpr
has evolved rapidly in the Theromyzon lineage (a derived
g r o u po fo l i g o c h a e t e s[ 29]), or gaps may exist in the
genome sequences of other leeches, possibly related to our
diﬃculties in cloning the Tpr 3
  end. Regardless, Tpr seems
likely to function at a transcriptional level based on its
hierarchical mRNA expression in newborn teloblasts, and its
characteristic glutamine-rich domain that is a hallmark of
transcriptional activation domains [27, 30].
5. Conclusion
We report a glutamine rich factor (Tpr) that is up-regulated
upon stem cell genesis in leech. Genetic knockdowns of Tpr
in early stage embryos prevent normal stem cell genesis,
resulting in abnormal cell proliferation and embryonic
death; Tpr knockdowns following stem cell birth display no
overt developmental abnormalities.
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